Home › Chronic Lymphocytic Leukemia › Minnesota › Duluth
Chronic Lymphocytic Leukemia clinical trials in Duluth, MN
4 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Duluth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecruitingPhase 3
- Essentia Health Cancer Center, Duluth
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- and 2 more
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- Essentia Health Cancer Center, Duluth
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
RecruitingPhase 2
- St. Lukes Hospital of Duluth /ID# 250021, Duluth
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Cincinnati, OH14 studies
- Chicago, IL14 studies
Other studies in Duluth
- Non-Small Cell Lung Cancer13 studies
- Lung Cancer11 studies
- Prostate Cancer7 studies
- Breast Cancer7 studies
- Colon Cancer6 studies
- Bladder Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Endometrial Cancer5 studies
- Stomach Cancer5 studies
- Rectal Cancer5 studies
- Esophageal Cancer5 studies
- Laryngeal Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.